{"id":"https://openalex.org/W20805557","doi":null,"title":"Social phobia: a pharmacologic treatment overview.","display_name":"Social phobia: a pharmacologic treatment overview.","publication_year":1995,"publication_date":"1995-01-01","ids":{"openalex":"https://openalex.org/W20805557","mag":"20805557","pmid":"https://pubmed.ncbi.nlm.nih.gov/7782272"},"language":"en","primary_location":{"id":"pmid:7782272","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7782272","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103558948","display_name":"James W. Jefferson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"J W Jefferson","raw_affiliation_strings":["Dean Foundation for Health, Resarch and Education, Madison, Wis. 53717-1914, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dean Foundation for Health, Resarch and Education, Madison, Wis. 53717-1914, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5103558948"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":14.7127,"has_fulltext":false,"cited_by_count":184,"citation_normalized_percentile":{"value":0.99073972,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"56 Suppl 5","issue":null,"first_page":"18","last_page":"24"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/social-anxiety-disorder","display_name":"social anxiety disorder","score":0.9990000128746033},{"id":"https://openalex.org/keywords/drug-therapy","display_name":"pharmacotherapy","score":0.7990000247955322},{"id":"https://openalex.org/keywords/phenelzine","display_name":"phenelzine","score":0.9779999852180481},{"id":"https://openalex.org/keywords/brofaromine","display_name":"brofaromine","score":0.8330000042915344},{"id":"https://openalex.org/keywords/moclobemide","display_name":"moclobemide","score":1.0},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.968999981880188},{"id":"https://openalex.org/keywords/fluvoxamine","display_name":"fluvoxamine","score":0.9950000047683716},{"id":"https://openalex.org/keywords/sertraline","display_name":"sertraline","score":1.0},{"id":"https://openalex.org/keywords/benzodiazepines","display_name":"benzodiazepines","score":0.996999979019165},{"id":"https://openalex.org/keywords/clonazepam","display_name":"clonazepam","score":0.9990000128746033},{"id":"https://openalex.org/keywords/beta-adrenergic-receptor-blockers","display_name":"beta-adrenergic receptor blockers","score":0.9620000123977661},{"id":"https://openalex.org/keywords/performance-anxiety","display_name":"performance anxiety","score":0.8939999938011169},{"id":"https://openalex.org/keywords/psychiatric-comorbidity","display_name":"psychiatric comorbidity","score":0.6809999942779541}],"concepts":[{"id":"https://openalex.org/C2780237459","wikidata":"https://www.wikidata.org/wiki/Q421934","display_name":"Moclobemide","level":4,"score":0.9018371105194092},{"id":"https://openalex.org/C2777669559","wikidata":"https://www.wikidata.org/wiki/Q407617","display_name":"Sertraline","level":4,"score":0.70891934633255},{"id":"https://openalex.org/C2779910183","wikidata":"https://www.wikidata.org/wiki/Q409236","display_name":"Fluvoxamine","level":5,"score":0.6985001564025879},{"id":"https://openalex.org/C2781073023","wikidata":"https://www.wikidata.org/wiki/Q1747559","display_name":"Phenelzine","level":4,"score":0.688491940498352},{"id":"https://openalex.org/C2777127095","wikidata":"https://www.wikidata.org/wiki/Q175854","display_name":"Phobias","level":3,"score":0.6440932750701904},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.6187313795089722},{"id":"https://openalex.org/C2777545354","wikidata":"https://www.wikidata.org/wiki/Q3557657","display_name":"Social anxiety","level":3,"score":0.5932282209396362},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5039202570915222},{"id":"https://openalex.org/C2910020395","wikidata":"https://www.wikidata.org/wiki/Q175854","display_name":"Phobic disorder","level":3,"score":0.48861581087112427},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.48567473888397217},{"id":"https://openalex.org/C2779426884","wikidata":"https://www.wikidata.org/wiki/Q407988","display_name":"Clonazepam","level":2,"score":0.48037442564964294},{"id":"https://openalex.org/C2776317618","wikidata":"https://www.wikidata.org/wiki/Q544006","display_name":"Anxiety disorder","level":3,"score":0.4752219319343567},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.4227406084537506},{"id":"https://openalex.org/C542102704","wikidata":"https://www.wikidata.org/wiki/Q183257","display_name":"Psychotherapist","level":1,"score":0.3487272262573242},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3086332678794861},{"id":"https://openalex.org/C2776024655","wikidata":"https://www.wikidata.org/wiki/Q410867","display_name":"Monoamine oxidase","level":3,"score":0.26704347133636475},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.2653815746307373},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.15589973330497742},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1475708782672882},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.13974636793136597},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.07079941034317017},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008996","descriptor_name":"Monoamine Oxidase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010698","descriptor_name":"Phobic Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010698","descriptor_name":"Phobic Disorders","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D010698","descriptor_name":"Phobic Disorders","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D011613","descriptor_name":"Psychotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015897","descriptor_name":"Comorbidity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015995","descriptor_name":"Prevalence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:7782272","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7782272","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Journal Article"},{"id":"mag:20805557","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7782272","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2025789187","https://openalex.org/W3140586347","https://openalex.org/W2049821022","https://openalex.org/W2140616228","https://openalex.org/W2062025998","https://openalex.org/W2397508356","https://openalex.org/W2038571342","https://openalex.org/W2010983145","https://openalex.org/W2081788276","https://openalex.org/W2412982587"],"abstract_inverted_index":{"Generalized":[0],"and":[1,8,50,53,69,73],"specific":[2,111],"social":[3,24,83,112,122,132],"phobias":[4],"are":[5],"common,":[6],"chronic,":[7],"potentially":[9],"debilitating":[10],"conditions.":[11,144],"In":[12],"recent":[13],"years,":[14],"there":[15],"have":[16,39,61,77,100],"been":[17,78,101,126],"major":[18],"advances":[19],"in":[20,64,120],"the":[21,138],"pharmacotherapy":[22],"of":[23,35,141],"phobia;":[25],"efficacy":[26,94],"has":[27,88,124],"become":[28],"better":[29],"established":[30],"for":[31],"a":[32,89],"diverse":[33],"group":[34],"medications.":[36],"Controlled":[37],"studies":[38],"shown":[40,62],"substantial":[41],"benefit":[42],"from":[43],"monamine":[44],"oxidase":[45],"inhibitors,":[46],"both":[47],"irreversible":[48],"(phenelzine)":[49],"reversible":[51],"(brofaromine":[52],"moclobemide).":[54],"The":[55,75,96],"serotonin":[56],"selective":[57],"reuptake":[58],"inhibitor":[59],"antidepressants":[60],"promise":[63],"case":[65],"reports,":[66],"uncontrolled":[67],"studies,":[68],"double-blind":[70,91],"trials":[71],"(fluvoxamine":[72],"sertraline).":[74],"benzodiazepines":[76],"extensively":[79],"used":[80,103],"to":[81,109,131],"treat":[82,110],"phobia,":[84],"although":[85,117],"only":[86],"recently":[87],"controlled,":[90],"study":[92],"confirmed":[93],"(clonazepam).":[95],"beta-adrenergic":[97],"receptor":[98],"blockers":[99],"widely":[102],"on":[104],"an":[105],"as":[106],"needed":[107],"basis":[108],"phobia":[113,123,133],"(i.e.,":[114],"performance":[115],"anxiety),":[116],"their":[118],"value":[119],"generalized":[121],"not":[125],"convincing.":[127],"Finally,":[128],"pharmacologic":[129],"approaches":[130],"must":[134],"take":[135],"into":[136],"consideration":[137],"common":[139],"coexistence":[140],"other":[142],"psychiatric":[143]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":5}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}